{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T18:18:18Z","timestamp":1790360298570,"version":"4.1.0"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2008,12,18]],"date-time":"2008-12-18T00:00:00Z","timestamp":1229558400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2008,12,18]],"date-time":"2008-12-18T00:00:00Z","timestamp":1229558400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gene Ther"],"published-print":{"date-parts":[[2009,3]]},"DOI":"10.1038\/gt.2008.180","type":"journal-article","created":{"date-parts":[[2008,12,18]],"date-time":"2008-12-18T06:24:45Z","timestamp":1229581485000},"page":"415-425","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Interleukin-6 small interfering RNA improved the herpes simplex virus-induced systemic inflammation in vivo Behcet\u2019s disease-like mouse model"],"prefix":"10.1038","volume":"16","author":[{"given":"J","family":"Shim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H O","family":"Byun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y D","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E S","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Sohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,12,18]]},"reference":[{"key":"BFgt2008180_CR1","doi-asserted-by":"crossref","first-page":"596","DOI":"10.47102\/annals-acadmedsg.V33N5p596","volume":"33","author":"N Akdeniz","year":"2004","unstructured":"Akdeniz N, Esrefoglu M, Kele\u00b0 MS, Karakuzu A, Atasoy M . Serum interleukin-2, interleukin-6, tumour necrosis factor-alpha and nitric oxide levels in patients with Behcet's disease. Ann Acad Med Singapore 2004; 33: 596\u2013599.","journal-title":"Ann Acad Med Singapore"},{"key":"BFgt2008180_CR2","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/S0167-4889(02)00325-7","volume":"1592","author":"KJ Kallen","year":"2002","unstructured":"Kallen KJ . The role of trans signalling via the agonistic soluble IL-6 receptor in human diseases. Biochim Biophys Acta 2002; 1592: 323\u2013343.","journal-title":"Biochim Biophys Acta"},{"key":"BFgt2008180_CR3","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1042\/bj2650621","volume":"265","author":"PC Heinrich","year":"1990","unstructured":"Heinrich PC, Castell JV, Andus T . Interleukin-6 and the acute phase response. Biochem 1990; 265: 621\u2013636.","journal-title":"Biochem"},{"key":"BFgt2008180_CR4","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/0090-1229(92)90042-M","volume":"62","author":"T Hirano","year":"1992","unstructured":"Hirano T . Interleukin-6 and its relation to inflammation and disease. Clin Immunol Immunopathol 1992; 62: 60\u201365.","journal-title":"Clin Immunol Immunopathol"},{"key":"BFgt2008180_CR5","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/0923-1811(95)00439-4","volume":"11","author":"Y Yamakawa","year":"1996","unstructured":"Yamakawa Y, Sugita Y, Nagatani T, Takahashi S, Yamakawa T, Tanaka S et al. Interleukin-6 in patients with Behcet's disease. J Dermatol Sci 1996; 11: 189\u2013195.","journal-title":"J Dermatol Sci"},{"key":"BFgt2008180_CR6","first-page":"599","volume":"10","author":"CR LinksWang","year":"1992","unstructured":"LinksWang CR, Chuang CY, Chen CY . Anticardiolipin antibodies and interleukin-6 in cerebrospinal fluid and blood of Chinese patients with neuro-Beh\u00e7et's syndrome. Clin Exp Rheumatol 1992; 10: 599\u2013602.","journal-title":"Clin Exp Rheumatol"},{"key":"BFgt2008180_CR7","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1076\/ocii.12.1.53.28062","volume":"12","author":"Y Bardak","year":"2004","unstructured":"Bardak Y, Arido\u2202an BC . The demonstration of serum interleukin 6-8, tumor necrosis factor-alpha, complement, and immunoglobulin levels in Beh\u00e7et's disease with ocular involvement. Ocul Immunol Inflamm 2004; 12: 53\u201358.","journal-title":"Ocul Immunol Inflamm"},{"key":"BFgt2008180_CR8","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s004030000128","volume":"292","author":"CC Zouboulis","year":"2000","unstructured":"Zouboulis CC, Katsantonis J, Ketteler R, Treudler R, Kaklamani E, Hornemann S et al. Adamantiades-Beh\u00e7et's disease: interleukin-8 is increased in serum of patients with active oral and neurological manifestations and is secreted by small vessel endothelial cells. Arch Dermatol Res 2000; 292: 279\u2013284.","journal-title":"Arch Dermatol Res"},{"key":"BFgt2008180_CR9","doi-asserted-by":"crossref","unstructured":"Choi B, Hwang Y, Kwon HJ, Lee ES, Park KS, Bang D et al. Tumor necrosis factor alpha small interfering RNA decreases herpes simplex virus-induced inflammation in a mouse model. J Dermatol Sci 2008; in press.","DOI":"10.1016\/j.jdermsci.2008.05.001"},{"key":"BFgt2008180_CR10","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1111\/j.1365-2133.1995.tb02655.x","volume":"133","author":"D Se\u00e7kin","year":"1995","unstructured":"Se\u00e7kin D, Akpolat T, Oltulu Y, Erkan D, Cant\u00fcrk T, Adam B et al. Serum lipoprotein (a) levels in Beh\u00e7et's disease. Br J Dermatol 1995; 133: 342.","journal-title":"Br J Dermatol"},{"key":"BFgt2008180_CR11","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1111\/j.1365-4362.1986.tb02232.x","volume":"25","author":"AU M\u00fcft\u00fco\u2202lu","year":"1986","unstructured":"M\u00fcft\u00fco\u2202lu AU, Yazici H, Yurdakul S, T\u00fcz\u00fcn Y, Pazarli H, G\u00fcngen G et al. Relation of serum Creactive protein and erythrocyte sedimentation rates to disease activity. Int J Dermatol 1986; 25: 235\u2013239.","journal-title":"Int J Dermatol"},{"key":"BFgt2008180_CR12","first-page":"904","volume":"22","author":"A al-Dalaan","year":"1995","unstructured":"al-Dalaan A, al-Sedairy S, al-Balaa S, al-Janadi M, Elramahi K, Bahabri S . Enhanced interleukin 8 secretion in circulation in patients with Beh\u00e7et's disease. J Rheumatol 1995; 22: 904\u2013907.","journal-title":"J Rheumatol"},{"key":"BFgt2008180_CR13","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1159\/000018426","volume":"201","author":"J Katsantonis","year":"2000","unstructured":"Katsantonis J, Adler Y, Orfanos CE, Zouboulis CC . Adamantiades\u2013Beh\u00e7et's disease: serum IL-8 is more reliable marker for disease activity than C-reactive protein and erythrocyte sedimentation rate. Dermatology 2000; 201: 37\u201339.","journal-title":"Dermatology"},{"key":"BFgt2008180_CR14","first-page":"321","volume":"23","author":"N Sayinalp","year":"1996","unstructured":"Sayinalp N, Ozcebe OI, Ozdemir O, Haznedaro\u2202lu IC, D\u00fcndar S, Kirazli S . Cytokines in Beh\u00e7et's disease. J Rheumatol 1996; 23: 321\u2013322.","journal-title":"J Rheumatol"},{"key":"BFgt2008180_CR15","first-page":"21","volume":"8","author":"S Sohn","year":"1998","unstructured":"Sohn S, Lee ES, Bang D, Lee S . Beh\u00e7et's disease-like symptoms induced by the Herpes simplex virus in ICR mice. Eur J Dermatol 1998; 8: 21\u201323.","journal-title":"Eur J Dermatol"},{"key":"BFgt2008180_CR16","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1111\/j.1468-3083.2004.00907.x","volume":"18","author":"B Adam","year":"2004","unstructured":"Adam B, Calikoglu E . Serum interleukin-6, procalcitonin and C-reactive protein levels in subjects with active Beh\u00e7et's disease. J Eur Acad Dermatol Venereol 2004; 18: 318\u2013320.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"BFgt2008180_CR17","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1080\/09629350220131935","volume":"11","author":"C Evereklioglu","year":"2002","unstructured":"Evereklioglu C, Er H, T\u00fcrk\u00f6z Y, Cekmen M . Serum levels of TNF-\u03b1, sIL-2R, IL-6, and IL-8 are increased and associated with elevated lipid peroxidation in patients with Beh\u00e7et's disease. Mediators Inflamm 2002; 11: 87\u201393.","journal-title":"Mediators Inflamm"},{"key":"BFgt2008180_CR18","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1006\/clin.1996.4268","volume":"82","author":"S Hirohata","year":"1997","unstructured":"Hirohata S, Isshi K, Oguchi H, Ohse T, Haraoka H, Takeuchi A et al. Cerebrospinal fluid interleukin-6 in progressive Neuro-Beh\u00e7et's syndrome. Clin Immunol Immunopathol 1997; 82: 12\u201317.","journal-title":"Clin Immunol Immunopathol"},{"key":"BFgt2008180_CR19","doi-asserted-by":"publisher","first-page":"12099","DOI":"10.1073\/pnas.0705268104","volume":"104","author":"A Kimura","year":"2007","unstructured":"Kimura A, Naka T, Kishimoto T . IL-6-dependent and -independent pathways in the development of interleukin 17-producing T helper cells. Proc Natl Acad Sci USA 2007; 104: 12099\u201312104.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFgt2008180_CR20","doi-asserted-by":"publisher","first-page":"5149","DOI":"10.4049\/jimmunol.172.9.5149","volume":"172","author":"MC Fantini","year":"2004","unstructured":"Fantini MC, Becker C, Monteleone G, Pallone F, Galle PR, Neurath MF . TGF-beta induces a regulatory phenotype in CD4+CD25\u2212 T cells through Foxp3 induction and down-regulation of Smad7. J Immunol 2004; 172: 5149\u20135153.","journal-title":"J Immunol"},{"key":"BFgt2008180_CR21","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1126\/science.1079490","volume":"299","author":"S Hori","year":"2003","unstructured":"Hori S, Nomura T, Sakaguchi S . Control of regulatory T cell development by the transcription factor Foxp3. Science 2003; 299: 1057\u20131061.","journal-title":"Science"},{"key":"BFgt2008180_CR22","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1038\/ni1539","volume":"8","author":"MJ McGeachy","year":"2007","unstructured":"McGeachy MJ, Bak-Jensen KS, Chen Y, Tato CM, Blumenschein W, McClanahan T et al. TGF-beta and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain T(H)-17 cell-mediated pathology. Nat Immunol 2007; 8: 1390\u20131397.","journal-title":"Nat Immunol"},{"key":"BFgt2008180_CR23","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1084\/jem.20041257","volume":"201","author":"CL Langrish","year":"2005","unstructured":"Langrish CL, Chen Y, Blumenschein WM, Mattson J, Basham B, Sedgwick JD et al. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med 2005; 201: 233\u2013240.","journal-title":"J Exp Med"},{"key":"BFgt2008180_CR24","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1111\/j.0105-2896.2004.00214.x","volume":"202","author":"CL Langrish","year":"2004","unstructured":"Langrish CL, McKenzie BS, Wilson NJ, de Waal Malefyt R, Kastelein RA, Cua DJ . IL-12 and IL-23: master regulators of innate and adaptive immunity. Immunol Rev 2004; 202: 96\u2013105.","journal-title":"Immunol Rev"},{"key":"BFgt2008180_CR25","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/S1074-7613(00)00070-4","volume":"13","author":"B Oppmann","year":"2000","unstructured":"Oppmann B, Lesley R, Blom B, Timans JC, Xu Y, Hunte B et al. Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity 2000; 13: 715\u2013725.","journal-title":"Immunity"},{"key":"BFgt2008180_CR26","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/978-3-540-73259-4_7","volume":"181","author":"N Nishimoto","year":"2008","unstructured":"Nishimoto N, Kishimoto T . Humanized antihuman IL-6 receptor antibody, tocilizumab. Handb Exp Pharmacol 2008; 181: 151\u2013160.","journal-title":"Handb Exp Pharmacol"},{"key":"BFgt2008180_CR27","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1002\/ibd.20148","volume":"13","author":"J Mudter","year":"2007","unstructured":"Mudter J, Neurath MF . Il-6 signaling in inflammatory bowel disease: pathophysiological role and clinical relevance. Inflamm Bowel Dis 2007; 13: 1016\u20131023.","journal-title":"Inflamm Bowel Dis"},{"key":"BFgt2008180_CR28","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/s10875-007-9104-0","volume":"27","author":"HY Chun","year":"2007","unstructured":"Chun HY, Chung JW, Kim HA, Yun JM, Jeon JY, Ye YM et al. Cytokine IL-6 and IL-10 as Biomarkers in Systemic Lupus Erythematosus. J Clin Immunol 2007; 27: 461\u2013466.","journal-title":"J Clin Immunol"},{"key":"BFgt2008180_CR29","doi-asserted-by":"publisher","first-page":"8008","DOI":"10.1128\/JVI.75.17.8008-8015.2001","volume":"75","author":"SR Paludan","year":"2001","unstructured":"Paludan SR . Requirements for the induction of interleukin-6 by herpes simplex virus-infected leukocytes. J Virol 2001; 75: 8008\u20138015.","journal-title":"J Virol"},{"key":"BFgt2008180_CR30","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1006\/viro.1996.0250","volume":"219","author":"S Kanangat","year":"1996","unstructured":"Kanangat S, Babu JS, Knipe DM, Rouse BT . HSV-1-mediated modulation of cytokine gene expression in a permissive cell line: selective upregulation of IL-6 gene expression. Virology 1996; 219: 295\u2013300.","journal-title":"Virology"},{"key":"BFgt2008180_CR31","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1038\/368339a0","volume":"368","author":"M Kopf","year":"1994","unstructured":"Kopf M, Baumann H, Freer G, Freudenberg M, Lamers M, Kishimoto T et al. Impaired immune and acute-phase responses in interleukin-6-deficient mice. Nature 1994; 368: 339\u2013342.","journal-title":"Nature"},{"key":"BFgt2008180_CR32","doi-asserted-by":"crossref","first-page":"8145","DOI":"10.1128\/JVI.73.10.8145-8151.1999","volume":"73","author":"RA LeBlanc","year":"1999","unstructured":"LeBlanc RA, Pesnicak L, Cabral ES, Godleski M, Straus SE . Lack of interleukin-6 (IL-6) enhances susceptibility to infection but does not alter latency or reactivation of herpes simplex virus type 1 in IL-6 knockout mice. J Virol 1999; 73: 8145\u20138151.","journal-title":"J Virol"},{"key":"BFgt2008180_CR33","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1016\/j.cell.2006.07.035","volume":"126","author":"II Ivanov","year":"2006","unstructured":"Ivanov II, McKenzie BS, Zhou L, Tadokoro CE, Lepelley A, Lafaille JJ et al. The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell 2006; 126: 1121\u20131133.","journal-title":"Cell"},{"key":"BFgt2008180_CR34","doi-asserted-by":"publisher","first-page":"17003","DOI":"10.1074\/jbc.M801286200","volume":"283","author":"K Ichiyama","year":"2008","unstructured":"Ichiyama K, Yoshida H, Wakabayashi Y, Chinen T, Saeki K, Nakaya M et al. Foxp3 Inhibits ROR{gamma}t-mediated IL-17A mRNA Transcription through Direct Interaction with ROR{gamma}t. J Biol Chem 2008; 283: 17003\u201317008.","journal-title":"J Biol Chem"},{"key":"BFgt2008180_CR35","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1016\/j.jaci.2004.06.023","volume":"114","author":"S Henness","year":"2004","unstructured":"Henness S, Johnson CK, Ge Q, Armour CL, Hughes JM, Ammit AJ . IL-17A augments TNF-alpha-induced IL-6 expression in airway smooth muscle by enhancing mRNA stability. J Allergy Clin Immunol 2004; 114: 958\u2013964.","journal-title":"J Allergy Clin Immunol"},{"key":"BFgt2008180_CR36","doi-asserted-by":"publisher","first-page":"271","DOI":"10.4049\/jimmunol.178.1.271","volume":"178","author":"S Wan","year":"2007","unstructured":"Wan S, Xia C, Morel L . IL-6 produced by dendritic cells from lupus-prone mice inhibits CD4+CD25+ T cell regulatory functions. J Immunol 2007; 178: 271\u2013279.","journal-title":"J Immunol"},{"key":"BFgt2008180_CR37","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1093\/intimm\/10.12.1969","volume":"10","author":"T Takahashi","year":"1998","unstructured":"Takahashi T, Kuniyasu Y, Toda M, Sakaguchi N, Itoh M, Iwata M et al. Immunologic self-tolerance maintained by CD25+CD4+ naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic\/suppressive state. Int Immunol 1998; 10: 1969\u20131980.","journal-title":"Int Immunol"},{"key":"BFgt2008180_CR38","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.4049\/jimmunol.173.2.1224","volume":"173","author":"AS McKee","year":"2004","unstructured":"McKee AS, Pearce EJ . CD25+CD4+ cells contribute to Th2 polarization during helminth infection by suppressing Th1 response development. J Immunol 2004; 173: 1224\u20131231.","journal-title":"J Immunol"},{"key":"BFgt2008180_CR39","doi-asserted-by":"publisher","first-page":"2747","DOI":"10.4049\/jimmunol.180.5.2747","volume":"180","author":"GJ van Mierlo","year":"2008","unstructured":"van Mierlo GJ, Scherer HU, Hameetman M, Morgan ME, Flierman R, Huizinga TW et al. TNFR-shedding by CD4+CD25+ regulatory T cells inhibits the induction of inflammatory mediators. J Immunol 2008; 180: 2747\u20132751.","journal-title":"J Immunol"},{"key":"BFgt2008180_CR40","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1093\/intimm\/dxm114","volume":"19","author":"D Noguchi","year":"2007","unstructured":"Noguchi D, Wakita D, Tajima M, Ashino S, Iwakura Y, Zhang Y et al. Blocking of IL-6 signaling pathway prevents CD4+ T cell-mediated colitis in a T(h)17-independent manner. Int Immunol 2007; 19: 1431\u20131440.","journal-title":"Int Immunol"},{"key":"BFgt2008180_CR41","doi-asserted-by":"publisher","first-page":"3025","DOI":"10.4049\/jimmunol.175.5.3025","volume":"175","author":"MJ McGeachy","year":"2005","unstructured":"McGeachy MJ, Stephens LA, Anderton SM . Natural recovery and protection from autoimmune encephalomyelitis: contribution of CD4+CD25+ regulatory cells within the central nervous system. J Immunol 2005; 175: 3025\u20133032.","journal-title":"J Immunol"},{"key":"BFgt2008180_CR42","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1084\/jem.20040812","volume":"200","author":"C Baecher-Allan","year":"2004","unstructured":"Baecher-Allan C, Hafler DA . Suppressor T cells in human diseases. J Exp Med 2004; 200: 273\u2013276.","journal-title":"J Exp Med"},{"key":"BFgt2008180_CR43","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1084\/jem.20031579","volume":"199","author":"V Viglietta","year":"2004","unstructured":"Viglietta V, Baecher-Allan C, Weiner HL, Hafler DA . Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis. J Exp Med 2004; 199: 971\u2013979.","journal-title":"J Exp Med"},{"key":"BFgt2008180_CR44","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1172\/JCI0213605","volume":"109","author":"A Kukreja","year":"2002","unstructured":"Kukreja A, Cost G, Marker J, Zhang C, Sun Z, Lin-Su K et al. Multiple immuno-regulatory defects in type-1 diabetes. J Clin Invest 2002; 109: 131\u2013140.","journal-title":"J Clin Invest"},{"key":"BFgt2008180_CR45","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1146\/annurev.immunol.21.120601.141122","volume":"22","author":"S Sakaguchi","year":"2004","unstructured":"Sakaguchi S . Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol 2004; 22: 531\u2013562.","journal-title":"Annu Rev Immunol"},{"key":"BFgt2008180_CR46","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.immuni.2006.01.001","volume":"24","author":"M Veldhoen","year":"2006","unstructured":"Veldhoen M, Hocking RJ, Atkins CL, Locksley RM, Stockinger B . TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 2006; 24: 179\u2013189.","journal-title":"Immunity"},{"key":"BFgt2008180_CR47","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1002\/art.20944","volume":"52","author":"S Yokota","year":"2005","unstructured":"Yokota S, Miyamae T, Imagawa T, Iwata N, Katakura S, Mori M et al. Therapeutic efficacy of humanized recombinant anti-interleukin-6 receptor antibody in children with systemic-onset juvenile idiopathic arthritis. Arthritis Rheum 2005; 52: 818\u2013825.","journal-title":"Arthritis Rheum"},{"key":"BFgt2008180_CR48","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1038\/nature01355","volume":"421","author":"DJ Cua","year":"2003","unstructured":"Cua DJ, Sherlock J, Chen Y, Murphy CA, Joyce B, Seymour B et al. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 2003; 421: 744\u2013748.","journal-title":"Nature"},{"key":"BFgt2008180_CR49","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1084\/jem.20041257","volume":"201","author":"CL Langrish","year":"2005","unstructured":"Langrish CL, Chen Y, Blumenschein WM, Mattson J, Basham B, Sedgwick JD et al. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med 2005; 201: 233\u2013240.","journal-title":"J Exp Med"},{"key":"BFgt2008180_CR50","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1172\/JCI21404","volume":"116","author":"D Yen","year":"2006","unstructured":"Yen D, Cheung J, Scheerens H, Poulet F, McClanahan T, McKenzie B et al. IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6. J Clin Invest 2006; 116: 1310\u20131316.","journal-title":"J Clin Invest"},{"key":"BFgt2008180_CR51","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1111\/j.1365-2133.2007.08403.x","volume":"158","author":"W Lew","year":"2008","unstructured":"Lew W, Chang JY, Jung JY, Bang D . Increased expression of interleukin-23 p19 mRNA in erythema nodosum-like lesions of Beh\u00e7et's disease. Br J Dermatol 2008; 158: 505\u2013511.","journal-title":"Br J Dermatol"},{"key":"BFgt2008180_CR52","doi-asserted-by":"publisher","first-page":"3959","DOI":"10.1182\/blood-2008-05-155846","volume":"112","author":"N Nishimoto","year":"2008","unstructured":"Nishimoto N, Terao K, Mima T, Nakahara H, Takagi N, Kakehi T . Mechanisms and pathological significances in increase in serum interleukin-6 (IL-6) and soluble IL-6 receptor after administration of an anti-IL-6 receptor antibody, tocilizumab, in patients with rheumatoid arthritis and Castleman's disease. Blood 2008; 112: 3959\u20133964.","journal-title":"Blood"},{"key":"BFgt2008180_CR53","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1136\/ard.2008.092932","volume":"67","author":"P Emery","year":"2008","unstructured":"Emery P, Keystone E, Tony HP, Cantagrel A, van Vollenhoven R, Sanchez A et al. IL-6 Receptor inhibition with tocilizumab improves treatment outcomes in patients with rheumatoid arthritis refractory to anti-TNF biologics: results from a 24-week multicentre Randomised Placebo Controlled Trial. Ann Rheum Dis 2008; 67: 1516\u20131523.","journal-title":"Ann Rheum Dis"},{"key":"BFgt2008180_CR54","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/S0022-510X(98)00165-8","volume":"159","author":"S Hirohata","year":"1998","unstructured":"Hirohata S, Suda H, Hashimoto T . Low-dose weekly methotrexate for progressive neuropsychiatric manifestations in Behcet\u2019s disease. J Neurol Sci 1998; 159: 181\u2013185.","journal-title":"J Neurol Sci"},{"key":"BFgt2008180_CR55","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1248\/bpb.30.603","volume":"30","author":"Y Hattori","year":"2007","unstructured":"Hattori Y, Maitani Y . DNA\/Lipid complex incorporated with fibronectin to cell adhesion enhances transfection efficiency in prostate cancer cells and xenografts. Biol Pharm Bul 2007; 30: 603\u2013607.","journal-title":"Biol Pharm Bul"},{"key":"BFgt2008180_CR56","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.virusres.2008.04.026","volume":"136","author":"RM Pawar","year":"2008","unstructured":"Pawar RM, Dhinakar Raj G, Senthil Kumar TMA, Raja A, Balachandran C . Effect of siRNA mediated suppression of signaling lymphocyte activation molecule on replication of peste des petits ruminants virus in vitro. Virus Res 2008; 136: 118\u2013123.","journal-title":"Virus Res"},{"key":"BFgt2008180_CR57","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1038\/ni1552","volume":"9","author":"HC Hsu","year":"2008","unstructured":"Hsu HC, Yang PA, Wang J, Wu Q, Myers R, Chen J et al. Interleukin 17-producing T helper cells and interleukin 17 orchestrate autoreactive germinal center development in autoimmune BXD2 mice. Nat Immunol 2008; 9: 124\u2013126.","journal-title":"Nat Immunol"},{"key":"BFgt2008180_CR58","doi-asserted-by":"publisher","first-page":"7128","DOI":"10.4049\/jimmunol.179.10.7128","volume":"179","author":"Y Yamaguchi","year":"2007","unstructured":"Yamaguchi Y, Fujio K, Shoda H, Okamoto A, Tsuno NH, Takahashi K et al. IL-17B and IL-17C Are Associated with TNF-alpha Production and Contribute to the Exacerbation of Inflammatory Arthritis. J Immunol 2007; 179: 7128\u20137136.","journal-title":"J Immunol"},{"key":"BFgt2008180_CR59","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.jaut.2007.07.004","volume":"29","author":"Z Liu","year":"2007","unstructured":"Liu Z, Jiu J, Liu S, Fa X, Li F, Du Y . Blockage of tumor necrosis factor prevents intestinal mucosal inflammation through down-regulation of interleukin-23 secretion. J Autoimmun 2007; 29: 187\u2013194.","journal-title":"J Autoimmun"},{"key":"BFgt2008180_CR60","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s00774-007-0766-8","volume":"25","author":"S Kamiya","year":"2007","unstructured":"Kamiya S, Nakamura C, Fukawa T, Ono K, Ohwaki T, Yoshimoto T et al. Effects of IL-23 and IL-27 on osteoblasts and osteoclasts: inhibitory effects on osteoclast differentiation. J Bone Miner Metab 2007; 25: 277\u2013285.","journal-title":"J Bone Miner Metab"},{"key":"BFgt2008180_CR61","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1093\/intimm\/dxm045","volume":"19","author":"M Nishihara","year":"2007","unstructured":"Nishihara M, Ogura H, Ueda N, Tsuruoka M, Kitabayashi C, Tsuji F et al. IL-6-gp130-STAT3 in T cells directs the development of IL-17+ Th with a minimum effect on that of Treg in the steady state. Int Immunol 2007; 19: 695\u2013702.","journal-title":"Int Immunol"},{"key":"BFgt2008180_CR62","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.bbrc.2008.03.059","volume":"370","author":"Y Sonobe","year":"2008","unstructured":"Sonobe Y, Liang J, Jin S, Zhang G, Takeuchi H, Mizuno T, Suzumura A . Microglia express a functional receptor for interleukin-23. Biochem Biophys Res Commun 2008; 370: 129\u2013133.","journal-title":"Biochem Biophys Res Commun"}],"container-title":["Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/gt2008180.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/gt2008180","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/gt2008180.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,7]],"date-time":"2024-03-07T01:34:55Z","timestamp":1709775295000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/gt2008180"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12,18]]},"references-count":62,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["BFgt2008180"],"URL":"https:\/\/doi.org\/10.1038\/gt.2008.180","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1158441.618600","asserted-by":"object"}]},"ISSN":["0969-7128","1476-5462"],"issn-type":[{"value":"0969-7128","type":"print"},{"value":"1476-5462","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,12,18]]},"assertion":[{"value":"15 August 2008","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2008","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2008","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2008","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}